Human anticoagulant vitamin‐K‐dependent protein S was expressed in mouse C127 cells using a bovine papilloma virus vector system. A full‐length cDNA construct was introduced into the vector in the 5′ untranslated region of the mouse metallothionein‐I gene. Transfected cells expressed approximately 10 μg/ml of the recombinant protein which was purified by ion‐exchange chromatography followed by affinity chromatography using Ca2+‐dependent monoclonal antibodies against the region of protein S containing 4‐carboxyglutamic acid. Recombinant protein S was structurally and functionally similar to protein S purified from plasma. On SDS/polyacrylamide‐gel electrophoresis recombinant protein S had a slightly higher molecular mass than plasma protein S. After treatment with endoglycosidase F, the proteins comigrated suggesting the observed molecular mass difference to be due to alterations in the N‐linked carbohydrate side chains. Recombinant and plasma protein S demonstrated identical amino‐terminal sequences, similar amino acid composition and number of 4‐carboxyglutamyl and 3‐hydroxyaspartyl/asparaginyl residues. Recombinant protein S had the same affinity for Ca2+ as protein S from plasma and the two proteins had the same activated protein C cofactor activity in a functional assay. In addition, both forms of protein S formed complexes with C4b‐binding protein with the same apparent Kd. Protein S is the most extensively post‐translationally modified vitamin‐K‐dependent protein, and all the modifications were carried out in the recombinant DNA system yielding a recombinant protein S with full biological activity. Copyright © 1990, Wiley Blackwell. All rights reserved